Biosafety considerations for attenuated measles virus vectors used in virotherapy and vaccination

Aline Baldo, Evanthia Galanis, Frédéric Tangy, Philippe Herman

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Attenuated measles virus (MV) is one of the most effective and safe vaccines available, making it attractive candidate vector to prevent infectious diseases. Attenuated MV have acquired the ability to use the complement regulator CD46 as a major receptor to mediate virus entry and intercellular fusion. Therefore, attenuated MV strains preferentially infect and destroy a wide variety of cancer cells making them also attractive oncolytic vectors. The use of recombinant MV vector has to comply with various regulatory requirements, particularly relating to the assessment of potential risks for human health and the environment. The present article highlights the main characteristics of MV and recombinant MV vectors used for vaccination and virotherapy and discusses these features from a biosafety point of view.

Original languageEnglish (US)
Pages (from-to)1-15
Number of pages15
JournalHuman Vaccines and Immunotherapeutics
DOIs
StateAccepted/In press - Mar 16 2016

Fingerprint

Measles virus
Vaccination
Virus Internalization
Communicable Diseases
Vaccines
Health
Neoplasms

Keywords

  • biosafety
  • measles virus (MV)
  • MV Edmonston strains
  • vaccination
  • viral vectors
  • virotherapy

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Pharmacology

Cite this

Biosafety considerations for attenuated measles virus vectors used in virotherapy and vaccination. / Baldo, Aline; Galanis, Evanthia; Tangy, Frédéric; Herman, Philippe.

In: Human Vaccines and Immunotherapeutics, 16.03.2016, p. 1-15.

Research output: Contribution to journalArticle

@article{3acde9a5521d4a7f951902f483aaadd3,
title = "Biosafety considerations for attenuated measles virus vectors used in virotherapy and vaccination",
abstract = "Attenuated measles virus (MV) is one of the most effective and safe vaccines available, making it attractive candidate vector to prevent infectious diseases. Attenuated MV have acquired the ability to use the complement regulator CD46 as a major receptor to mediate virus entry and intercellular fusion. Therefore, attenuated MV strains preferentially infect and destroy a wide variety of cancer cells making them also attractive oncolytic vectors. The use of recombinant MV vector has to comply with various regulatory requirements, particularly relating to the assessment of potential risks for human health and the environment. The present article highlights the main characteristics of MV and recombinant MV vectors used for vaccination and virotherapy and discusses these features from a biosafety point of view.",
keywords = "biosafety, measles virus (MV), MV Edmonston strains, vaccination, viral vectors, virotherapy",
author = "Aline Baldo and Evanthia Galanis and Fr{\'e}d{\'e}ric Tangy and Philippe Herman",
year = "2016",
month = "3",
day = "16",
doi = "10.1080/21645515.2015.1122146",
language = "English (US)",
pages = "1--15",
journal = "Human Vaccines and Immunotherapeutics",
issn = "2164-5515",
publisher = "Landes Bioscience",

}

TY - JOUR

T1 - Biosafety considerations for attenuated measles virus vectors used in virotherapy and vaccination

AU - Baldo, Aline

AU - Galanis, Evanthia

AU - Tangy, Frédéric

AU - Herman, Philippe

PY - 2016/3/16

Y1 - 2016/3/16

N2 - Attenuated measles virus (MV) is one of the most effective and safe vaccines available, making it attractive candidate vector to prevent infectious diseases. Attenuated MV have acquired the ability to use the complement regulator CD46 as a major receptor to mediate virus entry and intercellular fusion. Therefore, attenuated MV strains preferentially infect and destroy a wide variety of cancer cells making them also attractive oncolytic vectors. The use of recombinant MV vector has to comply with various regulatory requirements, particularly relating to the assessment of potential risks for human health and the environment. The present article highlights the main characteristics of MV and recombinant MV vectors used for vaccination and virotherapy and discusses these features from a biosafety point of view.

AB - Attenuated measles virus (MV) is one of the most effective and safe vaccines available, making it attractive candidate vector to prevent infectious diseases. Attenuated MV have acquired the ability to use the complement regulator CD46 as a major receptor to mediate virus entry and intercellular fusion. Therefore, attenuated MV strains preferentially infect and destroy a wide variety of cancer cells making them also attractive oncolytic vectors. The use of recombinant MV vector has to comply with various regulatory requirements, particularly relating to the assessment of potential risks for human health and the environment. The present article highlights the main characteristics of MV and recombinant MV vectors used for vaccination and virotherapy and discusses these features from a biosafety point of view.

KW - biosafety

KW - measles virus (MV)

KW - MV Edmonston strains

KW - vaccination

KW - viral vectors

KW - virotherapy

UR - http://www.scopus.com/inward/record.url?scp=84961390705&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84961390705&partnerID=8YFLogxK

U2 - 10.1080/21645515.2015.1122146

DO - 10.1080/21645515.2015.1122146

M3 - Article

SP - 1

EP - 15

JO - Human Vaccines and Immunotherapeutics

JF - Human Vaccines and Immunotherapeutics

SN - 2164-5515

ER -